In the process of tumor progression, the immune activity of T cells is dampened by upregulation of the immune checkpoint molecules such as PD-1/PD-L1 and CTLA-4 in the tumor microenvironment, resulting in tumor immune escape. Here, CD274 is linked to neoplasm.